We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Biopharma

Stay up to date on the topics that matter to you

Caroline Brandes profile page

Researcher – Early Drug Development, Miltenyi Biotec

Caroline Brandes, M.Sc. Molecular Biomedicine, joined Miltenyi Biotec in 2019 as a researcher in the early-stage drug development group of Dominik Lock. Since then, Caroline Brandes has been developing novel CAR and TCR T cell technologies for cancer immunotherapy, as well as non-viral T cell engineering and manufacturing processes with a focus on electroporation-based and genome-editing techniques.

Got a Question for Caroline Brandes?

Get in touch using the contact form linked here and we’ll get back to you shortly

Published Content

Total: 1

Online Event

Innovations in cell and gene therapy

Join key industry experts on June 14 at the Miltenyi Biotec innovations in cell and gene therapy online event.

Never miss a story

with the Breaking Science News daily newsletter